leukemia
137 projects
H2020Individual fellowship2019–2021Italy
LEUKEYOLK · Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis
H2020Individual fellowship2019–2021Italy
REPTOL · Pre-leukemic B cell repertoire alterations in patients with familial chronic lymphocytic leukemia: looking for evidence of a genetically-inherited defect in tolerance induction
H2020Individual fellowship2019–2020Spain
HifLICs · Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse
H2020Individual fellowship2019–2021Germany
CENTR-ALL · Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most common childhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL)
H2020Individual fellowship2018–2020United Kingdom
ProMeta · Non-histone protein acetylation targets of KAT2A in AML
H2020Individual fellowship2018–2020Greece
IGpath · Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas
H2020Individual fellowship2018–2020Spain
InTheMLLrBALL · Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia
H2020Individual fellowship2018–2020United Kingdom
Target5LO · Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia
H2020Individual fellowship2018–2020Denmark
TET2rec · Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions
H2020Individual fellowship2018–2019Italy
THAT IS HUNT · Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cell receptors
H2020Individual fellowship2018–2020Spain
CINK · Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers
H2020Individual fellowship2018–2019Denmark
DNAmethAML · Investigation of aberrant DNA methylation in malignant haematopoiesis
H2020Individual fellowship2017–2019United Kingdom
CATRATS · Catalytic Enantioselective Allene Cycloisomerisation Reactions for Alkaloid Total Synthesis
H2020Individual fellowship2017–2019Ireland
SAMNets · Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network
H2020Individual fellowship2017–2019Italy
EwiSarc · A novel in vivo platform to study and target undruggable Ewing onco-chimera.
H2020Individual fellowship2017–2019United Kingdom
SIOMICS · SIngle-cell multi-OMICs approach to study intra-tumour heterogeneity of soft tissue Sarcomas
H2020Individual fellowship2017–2019Switzerland
LEUKEMIC-TEs · Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia
H2020Individual fellowship2017–2019Italy
Targeting TopoII · Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward the rational design of novel anticancer drugs
H2020Individual fellowship2017–2019Germany
MARS · Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and genetic diseases: a multidisciplinary computational, structural and biological approach
H2020Doctoral network2016–2021Sweden
BioCapture · Smart capture phases for proteomics, glycomics and biomarker assays
14 partners · 7 countries
H2020Individual fellowship2016–2020Germany
HOXA9 degradome · Deciphering the machinery involved in stability of the transcription factor HOXA9.
2 partners · 2 countries
H2020Individual fellowship2016–2018United Kingdom
NVHSC · Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias
H2020Individual fellowship2016–2018Italy
CIRCLE · Investigation of the role of CYLD in Chronic Lymphocytic Leukaemia
H2020Individual fellowship2016–2018Austria